Submit Deal

EXALENZ BIOSCIENCE

Summary

Exalenz Bioscience develops and markets diagnostic tests and monitoring systems that use the breath to diagnose and help manage gastrointestinal and liver conditions.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 38 M

Avg. Deal Size£ 38 M

Market Context

Senior Management

Raffi Werner
CEO

Sort

19 Feb 2020|Israel|Biotechnology

Target: EXALENZ BIOSCIENCE

Bidder: MERIDIAN BIOSCIENCE

9 Service Providers

5 Target | 4 Bidder

10 Dealmakers

1 Target | 9 Bidder

£ 37 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy